Lynn Morris

机构：National Health Laboratory Service, University of the Witwatersrand · ORCID：0000-0003-3961-7828

发表论文 453 篇 · 总被引 29002 次 · h-index 86

代表论文

• Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials (2023 · PLoS Pathogens · 被引 57)
• Safety and pharmacokinetics of escalating doses of neutralising monoclonal antibody CAP256V2LS administered with and without VRC07-523LS in HIV-negative women in South Africa (CAPRISA 012B): a phase 1, dose-escalation, randomised controlled trial (2023 · The Lancet HIV · 被引 42)
• Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition (2023 · EBioMedicine · 被引 33)
• Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features (2024 · Proceedings of the National Academy of Sciences · 被引 24)
• High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials (2023 · Nature Communications · 被引 24)
• Functional HIV-1/HCV cross-reactive antibodies isolated from a chronically co-infected donor (2023 · Cell Reports · 被引 21)